Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label, Non-Comparative Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma

NCT00111020 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00111020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00111020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label, Non-Comparative Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2005
Completion date
October 31, 2008
Enrollment
2,567 (actual)
Sites
320

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, renal cell